18 June 2013
Keywords: fda, panel, declines, vote, rx-to-otc, switch, merck
Article | 23 July 1999
A US Food and Drug Administration advisory panel has not voted onwhether to recommend that Merck & Co's centrally-acting muscle relaxant
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 July 1999
21 July 1999
17 June 2013
© 2013 thepharmaletter.com